LTX-002

N/A

Report date: 2025/01/22 10:49:18

NME

Base Information

Drug NameLTX-002

Drug Alias NameLTX-002

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionSerine Palmitoyltransferase Long Chain Base Subunit 1 modulators

TargetsSerine Palmitoyltransferase Long Chain Base Subunit 1

Therapy Area/IndicationsPeripheral Nervous System DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPeripheral Nervous System DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease

Inactive IndicationsN/A

ATC CodeN/A